Caspase-3-triggered molecular self-assembling PET probes and uses thereof

US11679168B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11679168-B2
Application numberUS-201916570228-A
CountryUS
Kind codeB2
Filing dateSep 13, 2019
Priority dateSep 14, 2018
Publication dateJun 20, 2023
Grant dateJun 20, 2023

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Embodiments of the synthesis, radiolabeling and biological applications of an activatable tracer that undergoes intramolecular cyclization and aggregation upon activation by cleavage of a blocking moiety are provided. The probes of the disclosure allow for target-controlled self-assembly of small molecules in living subjects for imaging and drug delivery. The aggregated nanoprobes of the disclosure may be detectable optically, by PET detection, magnetic resonance imaging, and the like depending on the detectable reporter attached to the nanoprobe.

First claim

Opening claim text (preview).

What is claimed: 1. A compound having formula: 2. A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable carrier. 3. A method of imaging nanoaggregates in a subject, the method comprising: (i) administer to the subject a compound having formula: and (ii) obtaining an image of the nanoaggregates in the subject.

Assignees

Inventors

Classifications

  • the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu · CPC title

  • with the first amino acid being acidic · CPC title

  • A61K51/088Primary

    conjugates with carriers being peptides, polyamino acids or proteins (antibodies A61K51/10) · CPC title

  • Peptides, proteins, polyamino acids · CPC title

  • Methine dyes, e.g. cyanine dyes · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11679168B2 cover?
Embodiments of the synthesis, radiolabeling and biological applications of an activatable tracer that undergoes intramolecular cyclization and aggregation upon activation by cleavage of a blocking moiety are provided. The probes of the disclosure allow for target-controlled self-assembly of small molecules in living subjects for imaging and drug delivery. The aggregated nanoprobes of the disclo…
Who is the assignee on this patent?
Univ Leland Stanford Junior, The Board Of Trustees Of Leland Stanford Junior Univ
What technology area does this patent fall under?
Primary CPC classification A61K51/088. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jun 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).